Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
暂无分享,去创建一个
[1] G. Cabral,et al. Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. , 1999, The Journal of pharmacology and experimental therapeutics.
[2] M. Herkenham,et al. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Casellas,et al. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. , 1999, Molecular pharmacology.
[4] P. Casellas,et al. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. , 1999, The Journal of pharmacology and experimental therapeutics.
[5] M. Parmentier,et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.
[6] S. Galiègue,et al. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. , 1998, Blood.
[7] T. Klein,et al. Drugs of Abuse, Immunomodulation, and Aids , 1998, Advances in Experimental Medicine and Biology.
[8] C. Newton,et al. Cannabinoid receptors and immunity. , 1998, Immunology today.
[9] T. Klein,et al. Marijuana, immunity and infection , 1998, Journal of Neuroimmunology.
[10] P. Casellas,et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.
[11] V. Lagente,et al. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. , 1997, European journal of pharmacology.
[12] J. Allison,et al. Co-stimulation in T cell responses. , 1997, Current opinion in immunology.
[13] N. Kaminski,et al. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. , 1997, Toxicology and applied pharmacology.
[14] G. Cabral,et al. delta 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heat-stable antigen expression. , 1996, The Journal of pharmacology and experimental therapeutics.
[15] P. Casellas,et al. Cannabinoids enhance human B‐cell growth at low nanomolar concentrations , 1995, FEBS letters.
[16] S. Galiègue,et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.
[17] G. Cabral,et al. delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages. , 1995, The Journal of pharmacology and experimental therapeutics.
[18] T. Giese,et al. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. , 1995, Journal of immunology.
[19] P. Kaye,et al. Deficient expression of co‐stimulatory molecules on Leishmania‐infected macrophages , 1994, European journal of immunology.
[20] G. Das,et al. Macrophage – T cell interaction in experimental mycobacterial infection. Selective regulation of co‐stimulatory molecules on Mycobacterium‐ infected macrophages and its implication in the suppression of cell‐mediated immune response , 1994, European journal of immunology.
[21] M. Jenkins,et al. Surface proteins involved in T cell costimulation , 1994, Journal of leukocyte biology.
[22] A. Enk,et al. Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells. , 1994, Journal of immunology.
[23] M. Herkenham,et al. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. , 1994, The Journal of pharmacology and experimental therapeutics.
[24] Ronald N. Germain,et al. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.
[25] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[26] S. Munro,et al. Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.
[27] P. Casellas,et al. Cannabinoid-receptor expression in human leukocytes. , 1993, European journal of biochemistry.
[28] C. Newton,et al. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. , 1992, International journal of immunopharmacology.
[29] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[30] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[31] M. Herkenham,et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] T. Bonner,et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.
[33] R. Germain,et al. Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[34] K. McCoy,et al. Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. , 1998, International journal of immunopharmacology.
[35] C. Newton,et al. Cannabinoid receptors and the cytokine network. , 1998, Advances in experimental medicine and biology.
[36] C. Watts,et al. Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.
[37] Y. Daaka,et al. Expression of cannabinoid receptor mRNA in murine and human leukocytes. , 1995, Advances in experimental medicine and biology.
[38] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[39] M. Wiederhold,et al. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. , 1992, International journal of immunopharmacology.
[40] T. Mustelin,et al. Molecular events mediating T cell activation. , 1990, Advances in immunology.